Efficacy and safety of molnupiravir for the treatment of SARS-CoV-2 infection: a systematic review and meta-analysis

BACKGROUND: The role of molnupiravir for coronavirus disease 2019 (COVID-19) treatment is unclear. METHODS: We conducted a systematic review until 1 November 2022 searching for randomized controlled trials (RCTs) involving COVID-19 patients comparing molnupiravir [±standard of care (SoC)] versus SoC...

Descripción completa

Detalles Bibliográficos
Autores principales: Malin, Jakob J, Weibel, Stephanie, Gruell, Henning, Kreuzberger, Nina, Stegemann, Miriam, Skoetz, Nicole
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10320168/
https://www.ncbi.nlm.nih.gov/pubmed/37170886
http://dx.doi.org/10.1093/jac/dkad132

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10320168/
https://www.ncbi.nlm.nih.gov/pubmed/37170886
http://dx.doi.org/10.1093/jac/dkad132

Ejemplares similares